Dihydromyricetin (DHM)
Also called DHM, ampelopsin, vine tea extract, Ampelopsis grossedentata extract, DHM hangover supplement.
Best grade C across 3 graded outcomes Other Last checked
We earn a commission if you buy through links on this page. It never changes our grades or rankings. How we make money →
The short answer
From 9 sourcesDihydromyricetin is a plant flavonoid best known as a hangover ingredient, yet no placebo-controlled trial has tested isolated DHM for hangovers. Small RCTs in fatty liver (China, Greece) and type 2 diabetes reported better liver enzymes and glucose markers over one to twelve months. LiverTox rates it an unlikely cause of liver injury.
Quick pick
From a partner brand · paid linkNutricost Dihydromyricetin (DHM) Capsules, 90 count
from HerbsPro
Label: 1 capsule: 350 mg dihydromyricetin (from vine tea leaf extract, Ampelopsis grossedentata).
Best for trying one bottle: $15.95 one-time (checked Oct 15, 2026).
Every graded outcome on this page
3 rows · line = participantsKey facts
- What it is
- A flavonoid (also called ampelopsin) found in vine tea, Ampelopsis grossedentata, and in Hovenia dulcis13
- Hangover evidence
- No placebo-controlled trial of isolated DHM for hangover symptoms; a 2026 systematic review found the only clinical trials used Hovenia dulcis extracts, not isolated DHM, and a 2021 review of 82 hangover products found no peer-reviewed human data on any of them84
- Human trials
- Three small RCTs: 60 adults with fatty liver (3 months) and 80 with type 2 diabetes (1 month) from one Chongqing group, and 55 adults with fatty liver in Greece (12 months, DHM with vitamins C and E and choline)237
- Liver safety
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury): DHM has not been linked to serum enzyme elevations or liver injury cases1
What it is
DHM (dihydromyricetin, ampelopsin) is a flavonoid in vine tea (Ampelopsis grossedentata) and Hovenia dulcis, the Japanese raisin tree.
How it works
ProposedIn rats, DHM did not change alcohol dehydrogenase activity or how fast alcohol was cleared, although it lowered markers of oxidative stress in liver cells. In people, the two trials point to lower insulin resistance, with lower TNF-alpha and cytokeratin-18 fragments reported in the fatty-liver study.25
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Dihydromyricetin (DHM) forms compared
2 forms| 2 forms | DHM capsules (vine tea extract) | Vine tea (Ampelopsis grossedentata) leaf |
|---|---|---|
| Absorption in people | No human absorption data; LiverTox notes DHM is poorly absorbed and fairly rapidly metabolized.1 | No human absorption data in our sources.3 |
| GI tolerance | No drug-related adverse events in the 12-month Greek trial; LiverTox reports no liver injury cases.71 | The abstract does not report adverse events; 70 of 80 participants completed.3 |
| Studied for | Liver enzymes, glucose and lipids in fatty liver disease (600 mg/day for 3 months; 600 mg/day per the full text, 300 mg/day per the abstract, with vitamins C and E and choline for 12 months) | Fasting glucose and glycated albumin in type 2 diabetes (10 g/day, 1 month) |
- DHM capsules (vine tea extract)
- Absorption in people
- No human absorption data; LiverTox notes DHM is poorly absorbed and fairly rapidly metabolized.1
- GI tolerance
- No drug-related adverse events in the 12-month Greek trial; LiverTox reports no liver injury cases.71
- Studied for
- Liver enzymes, glucose and lipids in fatty liver disease (600 mg/day for 3 months; 600 mg/day per the full text, 300 mg/day per the abstract, with vitamins C and E and choline for 12 months)
- Vine tea (Ampelopsis grossedentata) leaf
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
3 graded outcomes, largest study firstAll 3 graded outcomes found an improvement. The largest, a 2019 randomized trial of 80 people on fasting glucose in type 2 diabetes, found an improvement.
1Fasting glucose in type 2 diabetes
Improved · Grade C · RCT, 80 people, 2019
Adults with type 2 diabetes (China); 70 completed
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Fasting glucose in type 2 diabetes | Improved | 80 | Grade C · RCT, 2019 | Adults with type 2 diabetes (China); 70 completed |
| Liver enzymes, glucose and lipids in non-alcoholic fatty liver disease | Improved | 60 | Grade C · RCT, 2015 | Adults with non-alcoholic fatty liver disease (China) |
| Liver enzymes, liver stiffness and glucose in fatty liver disease (MASLD) | Improved | 55 | Grade C · RCT, 2026 | Adults with metabolic dysfunction-associated steatotic liver disease (Greece); 9 withdrew (2 on DHM, 7 on placebo) |
Every graded row
3 rowsCGrade CFasting glucose in type 2 diabetesBlood glucoseLower fasting glucose and glycated albumin vs placeboRCT
n 80 · 2019
Improved Fasting plasma glucose, glycated albumin, cystatin C and retinol-binding protein 4 fell compared with placebo; lipids and apolipoproteins did not change.
- Design
- RCT, n = 80, 2019
- Population
- Adults with type 2 diabetes (China); 70 completed
- Form
- Vine tea (Ampelopsis grossedentata), 10 g/day containing 970 mg DHM; placebo was the same tea with DHM removed
- Dose
- 10 g vine tea daily (970 mg DHM)
- Duration
- 1 month
- Source
- Reference 3 · PubMed 30089792 (opens PubMed)
CGrade CLiver enzymes, glucose and lipids in non-alcoholic fatty liver diseaseFatty liver markersLower ALT, AST, GGT and HOMA-IR vs placeboRCT
n 60 · 2015
Improved Compared with placebo, ALT, AST, GGT, glucose, LDL cholesterol, apolipoprotein B and HOMA-IR fell; within the DHM group TNF-alpha, cytokeratin-18 fragment and FGF21 fell and adiponectin rose.
- Design
- RCT, n = 60, 2015
- Population
- Adults with non-alcoholic fatty liver disease (China)
- Form
- Dihydromyricetin capsules
- Dose
- Two 150 mg capsules twice daily (600 mg/day)
- Duration
- 3 months
- Source
- Reference 2 · PubMed 26032587 (opens PubMed)
CGrade CLiver enzymes, liver stiffness and glucose in fatty liver disease (MASLD)Fatty liver markersALT/GGT normalization 35% vs 5%RCT
n 55 · 2026
Improved Combined ALT and GGT normalization at 12 months was more frequent on the supplement (35% vs 5% per protocol; 32% vs 4% by intention to treat). Liver enzymes, glucose, HbA1c and total and LDL cholesterol fell, and liver stiffness was lower than baseline, only in the supplement group. No drug-related adverse events were reported.
- Design
- RCT, n = 55, 2026
- Population
- Adults with metabolic dysfunction-associated steatotic liver disease (Greece); 9 withdrew (2 on DHM, 7 on placebo)
- Form
- Hepatrat tablets: DHM with vitamins C and E and choline vs matching placebo
- Dose
- 2 tablets twice daily, 150 mg DHM per tablet: 600 mg/day in the full-text methods; the abstract states 300 mg/day
- Duration
- 12 months
- Source
- Reference 7 · PubMed 41612982 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Sold for hangovers, tested for blood sugar
One research group, plus a combination trial
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Doses studied in human trials ranged from 600 mg/day of DHM (3 months in capsules; 12 months in a tablet with vitamins C and E and choline, which the abstract gives as 300 mg/day) to 970 mg/day of DHM delivered in 10 g of vine tea for 1 month. No trial studied DHM before or after drinking alcohol.237
When trials measured an effect
2 outcomes| Outcome | Measured at | Basis |
|---|---|---|
| Lower fasting glucose in type 2 diabetes | 1 month (end of trial) | 80-person RCT of vine tea with 970 mg/day DHM3 |
| Lower liver enzymes in fatty liver disease | 3 months in the 2015 trial; 6 and 12 months in the 2026 trial | 60-person RCT of DHM capsules and 55-person RCT of a DHM, vitamin C, E and choline tablet27 |
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Dihydromyricetin and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Dihydromyricetin.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Liver
- LiverTox gives DHM a likelihood score of E (unlikely cause of clinically apparent liver injury): it has not been linked to serum enzyme elevations or liver injury cases. DHM is usually sold in multi-ingredient hangover blends whose other ingredients carry their own risks.14
- People on diabetes medicines
- The type 2 diabetes trial reported lower fasting glucose. NCCIH notes that supplements may interact with medicines and advises telling your health care providers about any supplement you use.36
- Pregnancy, breastfeeding and children
- No trial in our sources studied these groups, and NCCIH notes that many supplements have not been tested in pregnant women, nursing mothers or children.6
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksWhere to buy Dihydromyricetin (DHM)
Products from brands we partner with that contain Dihydromyricetin (DHM). Check the amount per serving against the doses studied above, and the label for other ingredients.
Dihydromyricetin (DHM) products from partner brands
1 product Paid links · we earn a commission- Quick pickHerbsProNutricost Dihydromyricetin (DHM) Capsules, 90 count
1 capsule: 350 mg dihydromyricetin (from vine tea leaf extract, Ampelopsis grossedentata)
$15.95one-timeChecked Oct 15, 2026
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes DHM work for hangovers?
Unproven. No placebo-controlled trial has tested isolated DHM for hangovers; a 2026 review found only two small trials of Hovenia dulcis extracts, which contain DHM among other compounds. A maker-funded 2026 observational study of a DHM and L-cysteine blend reported small next-day well-being gains (Cohen's d 0.20 to 0.32) without a placebo group. In rats, DHM did not speed the clearance of alcohol.895
Is DHM safe for the liver?
LiverTox reports that DHM preparations have not been linked to liver enzyme elevations or clinically apparent liver injury. Long-term safety has not been studied in trials.1
Can DHM be taken with diabetes medicines?
Is DHM the same as myricetin?
No. They are related flavonoids, but dihydromyricetin has its own LiverTox entry and its own small body of human research.1
What has DHM been tested for in people?
Three small RCTs. In China, 600 mg/day for 3 months in 60 adults with fatty liver lowered liver enzymes and insulin resistance, and vine tea with 970 mg/day DHM for 1 month in 80 adults with type 2 diabetes lowered fasting glucose. In Greece, a DHM tablet with vitamins and choline improved liver enzymes over 12 months in 55 adults.237
Sources
9 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
9 sources- 1Dihydromyricetin (LiverTox: Clinical and Research Information on Drug-Induced Liver Injury)Database LiverTox (NCBI Bookshelf), 2023 · ncbi.nlm.nih.gov
- 2Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.RCT Pharmacol Res, 2015 · PMID 26032587
- 3Ampelopsis grossedentata supplementation effectively ameliorates the glycemic control in patients with type 2 diabetes mellitus.RCT Eur J Clin Nutr, 2019 · PMID 30089792
- 4Unknown safety and efficacy of alcohol hangover treatments puts consumers at risk.Review Addict Behav, 2021 · PMID 34225031
- 5Does dihydromyricetin impact on alcohol metabolism.Animal study Physiol Res, 2020 · PMID 33656905
- 6Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
- 7Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial.RCT Ann Gastroenterol, 2026 · PMID 41612982
- 8Therapeutic Effects of Dihydromyricetin on Wholly Alcohol-Attributed Conditions: A Systematic Review.Systematic review Nutrients, 2026 · PMID 42514290
- 9Decentralized Assessment of a Dihydromyricetin- and L-Cysteine-Based Multi-Ingredient Dietary Supplement on Post-Alcohol Recovery: An Observational Cohort Study.Observational Nutrients, 2026 · PMID 42588049
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| evidence, safety, FAQ | Added the 2026 Greek 12-month RCT of a DHM, vitamin C, E and choline tablet in fatty liver disease (55 people; ITT rates, tablet contents and a 600 mg/day DHM dose from the PMC full text, which differs from the abstract's 300 mg/day; maker supplied the product), a 2026 systematic review and a maker-funded 2026 observational hangover study for the hangover key fact and FAQ, the LiverTox likelihood score (E) in the liver note and key fact, LiverTox's poor-absorption note, time-to-effect rows, an FAQ on diabetes medicines, hand-written questions and the metabolic goal hub. Summary, key facts and studied doses updated. Interactions checked: LiverTox (DHM, revised 2023) and the cited trials list none, NCCIH and MedlinePlus have no DHM page, and LactMed has no entry, so the list stays empty. | Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md |
| all | Initial editorial evidence review. Every PMID checked against NCBI E-utilities esummary (title, year, journal; none retracted) and each cited abstract read; numbers taken from the abstracts. Funding: neither trial abstract names a funder (Chongqing military medical university investigators; disclosed as not stated). Safety from LiverTox (DHM entry) and NCCIH's Using Dietary Supplements Wisely. Where to buy: Nutricost DHM 350 mg (product label checked 2026-10-15). | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.
